InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Mccluski Stephen C. Officer active across 2 companies, notably MONRO, INC.. Aggregated, 8 filings have been logged. Activity tracked since 6 August 2021. The latest transaction was disclosed on 11 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Stephen C. McCluski is a declarant linked to MONRO, INC. and ImmunoGen, Inc., where he is a director. He has 8 filings in total. In the sampled recent filings from 2021-08-10 to 2026-08-12, the modal transaction nature is Attribution, with 0 EUR of buys and 0 EUR of sells.